Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate: A Southwest Oncology Group study

M. E. Marshall, B. Blumenstein, E. D. Crawford, I. M. Thompson, J. B. Craig, M. Eisenberger, F. Ahmann

Research output: Contribution to journal › Article › peer-review